Conservative Treatment of Esotropia in Children up to 3 Years Old
Primary Purpose
Esotropia
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Prescription of spectacles
Sponsored by
About this trial
This is an interventional treatment trial for Esotropia
Eligibility Criteria
Inclusion Criteria:
- Within the age of 3 months to 3 years (inclusive infantile esotropia)
- Patients with constant or periodic esotropia and with revealed angle of deviation 5 degrees or over by Hirschberg test
- Patients with refractive errors (inclusive minor ametropias from 0.5 Dptr)
Exclusion Criteria:
- Age above 3 years
- Patients with neurological diseases and paralytic strabismus
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
spectacles
Arm Description
Esotropia is treated by full optical correction (spectacles prescription) in all children with refractive errors. Special attention is paid to astigmatism up to 0.5 Dptr. Intervention: Prescription of spectacles
Outcomes
Primary Outcome Measures
The angle of deviation
The absolute success is defined as restored symmetrical eye position.Qualified success is considered as reduction of the angle of deviation. Patients are examined 24 months later to assess outcome of treatment.
Secondary Outcome Measures
Full Information
NCT ID
NCT02404324
First Posted
December 23, 2014
Last Updated
April 9, 2017
Sponsor
National Centre of Ophthalmology named after academician Zarifa Aliyeva
1. Study Identification
Unique Protocol Identification Number
NCT02404324
Brief Title
Conservative Treatment of Esotropia in Children up to 3 Years Old
Official Title
Prescription of Full Optical Correction in Refractive Errors to Treat Esotropia in Children up to 3 Years Old
Study Type
Interventional
2. Study Status
Record Verification Date
March 2015
Overall Recruitment Status
Unknown status
Study Start Date
January 2012 (undefined)
Primary Completion Date
October 2017 (Anticipated)
Study Completion Date
November 2017 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
National Centre of Ophthalmology named after academician Zarifa Aliyeva
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The objective of this prospective study is the treatment of esotropia by prescribing the full precise optical correction of refractive errors in children up to 3 years old.
Detailed Description
This investigation includes children with esotropia associated with hyperopia, hypermetropic astigmatism, myopia, myopic astigmatism and minor ametropias. All children are prescribed full optical correction of refractive errors with special attention to astigmatism up to 0.5 Dpt to achieve maximal clear image on the retina of both eyes.If necessary, direct occlusion or penalization were administered to the children. The investigators suggest that this approach will give good results in the treatment of esotropia.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Esotropia
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
150 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
spectacles
Arm Type
Experimental
Arm Description
Esotropia is treated by full optical correction (spectacles prescription) in all children with refractive errors. Special attention is paid to astigmatism up to 0.5 Dptr.
Intervention: Prescription of spectacles
Intervention Type
Other
Intervention Name(s)
Prescription of spectacles
Intervention Description
All children are prescribed full optical correction of refractive errors with special attention to astigmatism up to 0.5 Dptr to achieve maximal clear image on the retina of both eyes.If necessary, direct occlusion or penalization are administered to the children.
Primary Outcome Measure Information:
Title
The angle of deviation
Description
The absolute success is defined as restored symmetrical eye position.Qualified success is considered as reduction of the angle of deviation. Patients are examined 24 months later to assess outcome of treatment.
Time Frame
2 years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
3 Months
Maximum Age & Unit of Time
3 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Within the age of 3 months to 3 years (inclusive infantile esotropia)
Patients with constant or periodic esotropia and with revealed angle of deviation 5 degrees or over by Hirschberg test
Patients with refractive errors (inclusive minor ametropias from 0.5 Dptr)
Exclusion Criteria:
Age above 3 years
Patients with neurological diseases and paralytic strabismus
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Elmar Kasimov, Professor
Organizational Affiliation
National Centre of Ophthalmology named after academician Zarifa Aliyeva
Official's Role
Study Director
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Conservative Treatment of Esotropia in Children up to 3 Years Old
We'll reach out to this number within 24 hrs